Non-surgical control of junctional and non-compressible hemorrhage via percutaneously delivered adjustable vessel occlusion
Active Definitive Contract Awarded Last action
- Contract number
- FA238424CB015
- Awardee
-
Amsel Medical Corporation UEI UUM9WLJWJQ24
- Awarding agency
-
Air Force
Department of Defense
- Obligated
- $5,510,841
Award facts
- Contract value 100% obligated
- $5,510,840.58 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- East Cambridge, MA 02141, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $966,377 | |
| Funding Only Action | $1,044,463 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,500,000 |
About this award
The Air Force awarded a definitive contract to Amsel Medical Corporation for non-surgical control of junctional and non-compressible hemorrhage via percutaneously delivered adjustable vessel occlusion on September 30, 2024, with a ceiling value of $5,510,840.58.
The contract is priced cost-plus-fixed-fee with no set-aside category. Place of performance is East Cambridge, MA. The ultimate completion date is April 29, 2027. Amsel Medical Corporation specializes in medical device research and development focused on hemorrhage control and emergency medical interventions for military and defense applications, with prior SBIR Phase II and Phase III awards from the Air Force Research Laboratory in this technology area.
Quick answers
Who was awarded contract FA238424CB015?
FA238424CB015 was awarded to Amsel Medical Corporation by Air Force (Department of Defense) on September 30, 2024.
How much is contract FA238424CB015 worth?
The government has obligated $5,510,841 on FA238424CB015.
Was contract FA238424CB015 competed?
The extent of competition for FA238424CB015 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award